Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

(2015) Celine M. Vachon et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical management of women at high risk of breast cancer

(2015) Melanie Wuttke et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

(2015) Jack Cuzick et al.   LANCET ONCOLOGY

Selective estrogen receptor modulators (SERMs): A review of clinical data

(2015) Sebastian Mirkin et al.   MATURITAS

Estimates of benefits and harms of prophylactic use of aspirin in the general population

(2014) J. Cuzick et al.   ANNALS OF ONCOLOGY

Aromatase Inhibitors in Breast Cancer Prevention

(2014) Jacqueline L. Olin et al.   ANNALS OF PHARMACOTHERAPY

Breast Cancer Prevention

(2014) David M. Euhus et al.   Breast Journal

Priorities for the primary prevention of breast cancer

(2014) Graham A. Colditz et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions

(2014) Lydia E. Pace et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Past, Present, and Future Challenges in Breast Cancer Treatment

(2014) George W. Sledge et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluating the Quality of Evidence from a Network Meta-Analysis

(2014) Georgia Salanti et al.   PLoS One

An update on the medical management of breast cancer

(2014) B. Yeo et al.   BMJ-British Medical Journal

Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial

(2013) Nancy R. Cook et al.   ANNALS OF INTERNAL MEDICINE

Conceptual and Technical Challenges in Network Meta-analysis

(2013) Andrea Cipriani et al.   ANNALS OF INTERNAL MEDICINE

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

(2013) A. DeCensi et al.   ANNALS OF ONCOLOGY

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Observational follow-up of the PROactive study: a 6-year update

(2013) E. Erdmann et al.   DIABETES OBESITY & METABOLISM

Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

(2013) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

(2013) Jack Cuzick et al.   LANCET

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals

(2013) Stein Emil Vollset et al.   LANCET

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

(2013) Jack Cuzick et al.   LANCET

Contralateral risk-reducing mastectomy in sporadic breast cancer

(2013) John A Murphy et al.   LANCET ONCOLOGY

Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons

(2013) Hwanhee Hong et al.   MEDICAL DECISION MAKING

Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates

(2013) Naomi Gronich et al.   Nature Reviews Clinical Oncology

Graphical Tools for Network Meta-Analysis in STATA

(2013) Anna Chaimani et al.   PLoS One

NICE recommends preventive drugs for breast cancer

(2013) J. Wise   BMJ-British Medical Journal

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene

(2012) Trevor J. Powles et al.   BREAST CANCER RESEARCH AND TREATMENT

Benefits and Harms of Detecting Clinically Occult Breast Cancer

(2012) Eitan Amir et al.   JNCI-Journal of the National Cancer Institute

The benefits and harms of breast cancer screening: an independent review

(2012)   LANCET

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

(2012) Christina Davies et al.   LANCET

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set

(2011) Mark J Bolland et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials

(2011) M. P. Goetz et al.   CLINICAL CANCER RESEARCH

Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3and/or Calcium (RECORD Trial)

(2011) Alison Avenell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Preventive therapy for breast cancer: a consensus statement

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

(2011) Paul E. Goss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

(2010) V. G. Vogel et al.   Cancer Prevention Research

GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

(2010) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

(2010) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis

(2010) Mary E. Ropka et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women

(2010) A. Z. LaCroix et al.   JNCI-Journal of the National Cancer Institute

Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women

(2009) Andrea Decensi et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk

(2009) S. R. Cummings et al.   JNCI-Journal of the National Cancer Institute

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Bazedoxifene, a selective estrogen receptor modulator

(2009) David F. Archer et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer

(2008) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk

(2008) D. Grady et al.   JNCI-Journal of the National Cancer Institute

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE